Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nickel might show up before I expected...! Sweet! Next station for this train is $.03!
Wow, look at the rollup of bigger money investing in ACOL on that chart this month starting the 12th. Looks like there was a confidence factor hurdle that was met at .005 and it's been breaking chains since it "proved itself" ever since. RSI is strong too. I like that pic.
My takeaways on that pic are A)8 of 10 days were positive since 12th, B)7 of 8 of those positive days were double digit increases in percentage, C)still in a strong RSI stream, and D)couple this with a drop of a record setting 10-k for 2016 and watch out!
That might be a pretty neat sell for a hospital to have it's own name/logo permanently right on the pill bottles! Right now it's limited to the printed wrap-around labels on the orange bottles (and wears/smudges/tears off waaaaay to easily); but one that's printed on with contact info could lead the way to much smaller label requirements for just the individual on the back... Hmmm.
Wow! Look at all those cheap shares getting scooped up! 30 min into day and already at 100-Day average volume transferred. She's coiling again.
Agree with BuddyGuise. I'm not seeing where that's coming from (the 1.8B number).
If Authorized Shares is 6B and 5,164,134,794 are issued per the 10-Q that leaves 835,865,206 available/unissued per the Sep 16 report. That means if all is still the same from the latest 10Q they could retire about 835M shares today at no cost to anyone except flexibility to the company (they can't issue/sell those shares to raise cash quick then; they would have to start coughing up insider shares then to raise funds instead). So if they took the step to reduce the A/O to match the already issued stock amount that would help "lock" the shares and increase value, momentum, and volatility with the added shareholder safeguard of a vote required to increase the A/O again (read=gives advance notice of intent).
Likewise, if they buyout and retire the insider shares it would further reduce the pool driving the remaining shares upwards in value while share structure reduces to become more desirable to be a shareholder. Right now the dilution/issuing of those available unissued shares and/or the insiders sale of shares into the market would be detriments to PPS value and not be value-builders for us shareholders. Basically, it's a threat to value and we're trusting the company not to dilute any more than is absolutely necessary until sales supports ops. If they do the right thing and arrest the issuing before running out, then the PPS value grows. If they reduce the A/O, value grows. If they reduce the insider holdings without releasing to the market, value grows. Alternatively, if they max out the shares issued, increase the A/O, or dump insider shares to market, I would expect PPS value to drop...and faith is lost in the company.
Having insiders hold shares indicates buy-in and skin-in-the-game interest. They WANT it to go up in value too! But what they do with them is very telling on company strategy.
Retiring shares might be unlikely, but it is still a possible tool for a real company trying to establish itself rising from pennyland into mainstream and wanting to be taken seriously. Another possibility is a reverse split to uplist as a reporting company, but that's a whole other ball of wax.
I'm looking forward to the 10-K; it should reveal a lot of what's hidden to us still... whether good, bad or indifferent.
All in my opinion and understanding of this situation.
Thanks and I'm honored you think highly of my opinion! I would be happy to speculate and play "what-if", opinions, etc once the missing piece of the equation is released. Right now the numbers are incomplete to draw anything more than rough trends. Buddyguise actually has done a lot of the legwork in his "ACOL Poised for Record Year" pinned post and is great info. I'm just waiting to fill in the missing green blocks for FY2016 (thus his disclaimers of only 3 qtrs represented in FY graphs). Which means...
We still have a whole 'nother block of green to show up still and stack on top of those bars for sales and margins in order to complete making 2016 a record setting year in and of itself...before we even start talking about 2017! That by itself is a big, BIG positive from where we are now because values are still being pulled from the Sep 2016 quarter.
That's also why market cap valuation will become key from here on out and where I pulled the pps in #9028 ($.09-.14) as being targets if A) sales continue current rate of climb (or increase slope) thru both contracts and/or individual sales and/or distribution points (points of sale), B) margins continue rate of climb or increase (remember re-investment back into company actually reduces profit margins) and C) changing the basis of valuation from wild speculation of a penny stock to an actual bricks-N-mortar company holding a patent, producing a real product meeting a demand, and proving itself in the marketplace (whoohoo!). Wild cards that can boost the speed it reaches its potential are things like provider contracts (sales), exponential customer base growth (sales), market penetration (exposure, thus sales), challenging patent infringements (IP thus protecting...sales), company buy-outs, etc.
Market demand and the ability of the company to meet will dictate everything.
Again, all in my humble opinion. And with this post iHub is cutting me off and saying I've done enough yakking for the day. We'll continue the ACOL trip tomorrow.
Wrong. They have different share structures. Same goal, just different ways of getting to same spot.
Example 1-If both Kush and Acol have $130M market caps. Kush has that cap spread out over 50M shares which equals $2.6/share. If Acol has same cap spread out over 5B shares it equals $.026/share.
Example 2-If both have $750M market caps. Kush has $15/share. Acol still only has $.15/share.
As I understand it, it gets more complicated when one owns an interest in another (like if Acol has 40% or even 100% of Kush), but it just converts to be "just another" asset (or liability) for the owning company's valuation; it's not a compounding market cap.
Yes, near as I can tell, that was the acquisition of D&C under the umbrella of ACOL and the move from an inactive holding company to an actively managed business providing a product. They had to pick up the ball at that point and run with it after the share structure established itself in the market. Now they have to go from low point to as far up as they can proving themselves as they go. Gee, wouldn't it be cool if they got back to $.50/share like it was when they started active trading?!?! That'd be a happy day.
That brings up a good point Jack! The sooner they were to retire shares the less "skin" they lose on the company side with a lower buyout, the faster the momentum moves with the remaining, and the more share value potential there is for everyone. Waiting until it's $.15 versus .05 isn't in the company's best interest if it has the profit margin to remove them from the pool.
But first step is they have to have the sales/profit to support any strategy...
Sorry I'm so talkative today...too much coffee.
Might be idealistic, but I'd like to see ACOL A)pull in big profits off sales in current configuration, B)Go debt-free, eliminate liabilities and position for contingencies/growth, C)lower share structure by retiring shares and amending A/O to show intent, D)secure growth capabilities on the manufacturing side to ensure no order goes unmet as the market grows beyond current configuration, and E)uplist and establish as the premier mainstream, serious business for decades to come...or it gets bought out.
Pretty much in that order of priority... but I'm not the boss. IMO only as a passenger on the train.
IMO, sure they "could", but that is exactly the kind of thinking and action that seems to separate those bad penny stocks from the good ones. The good would care and either stabilize or reduce, the bad ones increase into oblivion (sometimes slowly so people don't notice).
Does the company actually care and act in the best interest of the company, shareholders, and future or is it just a scam that dilutes, pushes value down and kills the company?
So far so good with ACOL imo. I think we're all here because we believe ACOL is more in the good category than in the scam. They seem to be moving in the right direction anyway. Now it's up to company management to prove good, bad, or indifferent. Which will be done with good investments (ie. expansion plans), good product(s), good business decisions, and good financials...or not.
FYI-Seeing them reduce share structure would cement my decision to which category they belong in... imo.
Stockherder-That's a page of beauty right there.
Of course if the company started to announce $100M exclusive-provider contracts (10M users x $10/per container) then all that goes out the window and suddenly $1B+ market cap becomes a very real possibility. O.O
And we can dream of a much different lifestyle... )))
Here's my "stab in the dark" guesstimate. You're looking for comparisons and number of shares. Suggestion=I change to compare market caps and then divide accordingly by share structures instead of trying to figure out shares against shares. ie. Kush is around $131M cap, ACOL is around $88M. If you try to go share-share those numbers put a modifier of 1.50017 per share or $.025'ish for ACOL to come up to equalization. Basically just do 131M market cap divided by 5.1B shares for ACOL.
That said, some companies are looking at 500-750M on market cap so someone remarked that $.09-.14 is a very real possibility...I tend to agree and then add emotion on top of that for possibilities...depends on momentum and exuberance (and a real good 4Q release or series of increasing sales/profits) and so on.
Amazingly blind exuberance "could" propel to $1, (like mdbx did from .002 to $200 back when) but it'd be a lightning strike of luck and company contracts on national scales, everyone holding shares in lockstep, bid support, etc...
All IMO of course. We'll find out what this baby can do together.
In answer for your comparison to ACOL.
Last 10q for KUSH shows: "
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.001 par value, 265,000,000 shares authorized, 49,391,896 and 48,300,162 shares issued and outstanding, respectively"
That said, I believe ACOL sales will show to be big and positive for last quarter. That will help reinforce overall positive trend and even gap up to match the enthusiasm/momentum for a real product/business/profit. IMO of course. Either way, it's already separating itself out of the pack of do-nothing sub-penny's... woot!
I'm in the exact same boat as you Karlstier. I'm just waiting on the 4Q/2016 to drop and that'll help answer a lot of the questions. We should be able to see how big the sales went and can look at trends with $ attached then.
There are. 5,164,134,794 to be exact.
Whatever iHub's formula is for the breakout must be broken. It's causing a lot of folks that watch the breakout to miss this phenomenal train...
They can come running along the tracks and climb aboard if they can catch us.
That's what I was asking about in #8959
Question for the iHub saavy folks on here. How did ACOL manage to NOT make it into the top 50 on the breakout board?!? or am I just missing it somewhere...hiding...blind... LOL
Silver=nickels and dimes. Basically, anywhere more than pennies (copper) and less than dollars. ie. $.05 to $.99
It does seem like folks are using price-triggered market sells rather than price-triggered limit sells...
Makes for a landmine pushing the price back down as the big block fills downward rather than a stable or upwards direction that would be achieved with a limit order.
Then we have to recover after each one goes off.
Just my impression.
Average volume hit 1 hour after open bell.
Shakedown of weak hands over imo. Heading back up. She's coiled for strike.
Already passed half of avg volume...
Whooo, opening bell surge! And we're off to the races!
Thanks FrankWhite. That's the part (owner owned) that I'm missing in the K's and Q's and I'm not seeing the disbursement forms to find remaining ownership. So if I have this right it's roughly 5.16B issued minus 3.8B ownership leaves about 1.3B for the float... right?
Ref:#8616
I hope so...
Ultimately the annual for 2016 will show whether or not anything changed... but as of Sep it looked well going into big sales. G'Luck!
OK, great, now we might get somewhere. First, go to http://www.nasdaq.com/symbol/acol/historical and set the filter to 5 years. Scroll down to 2014. Trading of the stock was alot of zeros in the volume at your worry point of $5. In fact, it was 122 shares that killed it from $5 to $1.50 on 7/07/2014 followed by several more sessions of zeroes. Trading didn’t even really start of any appreciable amount until October of 2014 when the price was at .50 starting out. The market cap at that point should have been (# of shares x price=$2.2B) and then 3 months later it was at $.05 (cap=227M) and it continued to slide.
That they ever diluted isn’t really in question, they had to have sold into the market at some point. So now let’s zero in on your statement that I was trying to answer, “my guess is market cap has flat lined while shares outstanding is up ~1,000% (or another tenfold more).”
I was answering that it hadn’t as far as I can see. A move of 4.6B to 5.1B outstanding shares is NOT a tenfold move of dilution. They instead took the hit on the share price that went from .5 to .0002.
Now that they have actual revenue coming in and a profit margin from sales they “could” dilute (to cover your low cash scenario) but why should they when it appears they are now (finally) on the upswing and can grow the cash on-hand out of sales without killing the share price more (and their own shares within the company). They didn’t change the outstanding from 2015-2016, so it looks like the bottom was hit and now it’s building with the same number of shares listed from 2015. Thus grow the price back up from revenue rather than from dilution...
Understand?
When they acquired D+C they may have valued the initial release of stock at $4.50 but they rode a hill down quickly til it hit the end of year value of .05 followed by a bottoming out in 2015. Now it's higher and growing; and gaining market cap (from it's bottom). Now if you're measuring from 2014 acquisition to now, you are absolutely correct the market cap is a fraction of what it was, but that's a function of stock value, not of issued shares since the outstanding only ramped up slightly.
The market cap at one point in 2015 (at increased share count and price at .0002; Jul/Aug 2015) was only $1,032,820. It's since gone up obviously from there to where the market believes is the current correct value.
As far as I can tell; now show me where it's wrong and I'll gladly appreciate the correction...
On 31 Dec 2014 close price was $.05. If there were ~4,460,000,000 shares (not exact) then market cap total would be around 223M. I'm not following your train of thought here, might want to check your numbers. Trade volume was zeroes prior to about Oct 2014 according to NASDAQ historical record when it took a nosedive out the gate.
And yes, I'm new. So what. Show me where I'm wrong then.
I'm confused, how and where did we start talking about cash on hand?
I got bored so I actually made that very chart you're describing. I can't post a chart or even a JPG here...grrr. But it's basically the opposite of what you describe. The Shares increased from '14-15 but flatlined to current. The market cap (based on closing prices of 31Dec of each year shows a big decrease in 14 (of course) a bottom in 15 and an increase for 16. Followed by a large increase just this month (using static share count value).
Looks like a company recovering from bad times investing in infrastructure/equipment/personnel and starting to see growth/revenue/results finally from this viewpoint. In my opinion of course.
Looking forward to tomorrow and this week.
The SEC filings (annual report ending 31Dec15) show 700M worth of "Issuance of Common Stock in Private Placement" which would explain where some are getting a 700M float but from the same report there is a second "Issuance of Common Stock in Private Placement" of 428,571,429. Which brings it up to 1,128,571,429 or what Scottrade shows as 1.2B. That may play into this (my)confusion...
And thanks for posting that filing FrankWhite, that helped in trying to track this down! That clearly denotes the 700M for the 2015 offering.
Per the financials on Ihub:
Total Common Shares Out on 2014/12=4546.0M
Total Common Shares Out on 2015/12=5164.1M
Total Common shares Out on 2016/09=5164.1M
Of 6B Authorized
There currently is a discrepancy (that I see) between Scottrade, Ihub, MarketWatch and others on what the actual number is for the Float in the market. Some have 700.05M, I know Scottrade lists 1.2B, MarketWatch is around 1.4B. Someone else will have to clear up why there is a disconnect being shown (for mine and other's benefit) for what should be a clear, black and white number of what's available to the market... preferably with where they are pulling their number from and why institutions are differing.
Regardless of what that ends up being, the stock is still going up (imo) just based on the market cap value alone and sales of product growth.
You know you're onto something good when people are complaining about holidays... LOL!
So let me see if I got this right… originally designed for palliative, senior living, and children (those without the ability to swallow pills) it hit the market with the nursing homes and such. Then it was picked up by the MMJ crowd which ended up finding out it’s a phenomenal product for grinding their herbs and it’s in the process of skyrocketing now. And now it’s been found to be a perfect match for yet another market niche of pipe tobacco smokers as well? This just keeps getting better and better; and growing! Link:
It's a sleeper... A sleeper that just woke up.